New User? Sign Up | Sign In

Insider Trading - Myers Scott Dunseth

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Myers Scott Dunseth

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-06-28
Purchase
2016-06-28
5:36 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
62,500 $0.8 $50,000 62,500
(Direct)
View
2016-08-17
Purchase
2016-08-18
5:16 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
45,000 $1.1499 $51,745 107,500
(Direct)
View
2017-01-27
Purchase
2017-01-31
4:55 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
20,500 $3.758 $77,039 38,416
(Direct)
View
2017-03-20
Purchase
2017-03-21
8:09 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
1,000 $3.9271 $3,927 39,416
(Direct)
View
2017-03-31
Purchase
2017-04-04
5:39 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
2,000 $4.1143 $8,229 41,416
(Direct)
View
2017-05-12
Purchase
2017-05-16
5:43 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
2,800 $3.997 $11,192 44,216
(Direct)
View
2017-08-11
Purchase
2017-08-14
5:12 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
5,500 $3.735 $20,542 49,716
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-04-04
Option Award
2016-04-06
5:07 pm
N/A
2024-04-04
Oncothyreon Inc. ONTY Myers Scott Dunseth
CEO
2,848,855 $1.18 2,848,855
(Direct)
View
2017-01-11
Option Award
2017-01-13
7:48 pm
N/A
2027-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
190,000 $4.64 42,000
(Direct)
View
2017-01-11
Option Award
2017-01-13
7:48 pm
N/A
2021-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
42,000 $0 42,000
(Direct)
View
2017-09-18
Option Award
2017-09-20
9:07 pm
N/A
2027-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
60,000 $3.99 15,500
(Direct)
View
2017-09-18
Option Award
2017-09-20
9:07 pm
N/A
2021-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
15,500 $0 15,500
(Direct)
View
2017-11-10
Option Award
2017-11-13
8:00 pm
N/A
2021-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
6,300 $0 6,300
(Direct)
View
2018-01-11
Exercise
2018-01-16
5:26 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
10,500 $0 31,500
(Direct)
View
2018-01-11
Tax Withholding
2018-01-16
5:26 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
3,429 $3.92 31,500
(Direct)
View
2018-01-11
Exercise
2018-01-16
5:26 pm
N/A
2027-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
10,500 $0 31,500
(Direct)
View
2018-02-01
Option Award
2018-02-02
5:54 pm
N/A
2022-02-01
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
250,000 $0 250,000
(Direct)
View
2018-03-09
Equity Swap
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
56,787 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
2026-04-04
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
474,810 $7.08 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
2027-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
190,000 $4.64 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
2027-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
60,000 $3.99 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
42,000 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
15,500 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
6,300 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
250,000 $0 0
(Direct)
View
2019-06-03
Option Award
2019-06-05
5:30 pm
N/A
2029-06-02
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $11.84 10,167
(Direct)
View
2019-06-14
Option Award
2019-06-18
4:21 pm
N/A
2029-06-13
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
20,000 $2.1 20,000
(Direct)
View
2019-08-20
Option Award
2019-08-20
4:32 pm
N/A
N/A
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
41,436 $1.81 41,436
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
N/A
N/A
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
39,409 $1.46 19,704
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
2019-12-23
2024-12-23
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
19,704 $0.125 19,704
(Direct)
View
2020-04-28
Option Award
2020-04-30
5:02 pm
N/A
2030-04-28
AMAG PHARMACEUTICALS Inc AMAG Myers Scott Dunseth
CEO
1,000,000 $8.2 1,000,000
(Direct)
View
2020-05-28
Option Award
2020-06-01
9:50 pm
N/A
2030-05-27
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $20.59 10,167
(Direct)
View
2020-06-19
Option Award
2020-06-23
4:47 pm
N/A
2030-06-18
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
20,000 $3 20,000
(Direct)
View
2020-11-16
Disposition
2020-11-17
3:42 pm
N/A
N/A
AMAG PHARMACEUTICALS Inc AMAG Myers Scott Dunseth
CEO
1,000,000 $0 0
(Direct)
View